{"id":"W2090321716","doi":"10.1038/sj.clpt.6100510","title":"Human Abuse Liability of the Smoking Cessation Drug Varenicline in Smokers and Nonsmokers","year":2008,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"Pfizer","keywords":"Varenicline; Placebo; Partial agonist; Drug; Abuse liability; Medicine; Pharmacology; Smoking cessation; Crossover study; Agonist; Nicotinic agonist; Clinical pharmacology; Amphetamine; Anesthesia; Nicotine; Psychiatry; Internal medicine; Receptor; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008544075,0.0001583743,0.0002415066,0.0003184601,0.0002253802,0.000243567,0.0001029657,0.00038946,0.001847383],"category_scores_gemma":[0.001570365,0.0002182036,0.0002096319,0.00009745326,0.0003205934,0.0002252657,0.000211415,0.0003430083,0.0002268984],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001412126,"about_ca_system_score_gemma":0.0001637413,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006863418,"about_ca_topic_score_gemma":0.0008560373,"domain_scores_codex":[0.9994124,0.0003526402,0.0000301299,0.00004499714,0.0001134099,0.0000464055],"domain_scores_gemma":[0.9994235,0.0002500867,0.0001148311,0.00005873547,0.00003884437,0.0001140623],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.05575253,0.01521421,0.4282493,0.0002882516,0.0006618116,0.001070132,0.002260525,0.0004584368,0.3632363,0.0009629035,0.0005821993,0.1312634],"study_design_scores_gemma":[0.0009740419,0.1371848,0.8229229,0.00003437851,0.0002815079,0.003031177,0.0009380049,0.001753829,0.03026301,0.0004726637,0.002108128,0.00003545566],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9991924,0.0003307641,0.00005406903,0.00001759699,0.000003527654,0.00001647173,0.00001829298,0.000001583806,0.0003651697],"genre_scores_gemma":[0.9989516,0.0004833807,0.0001092548,0.00003255928,0.00001005483,0.00001631151,0.00004949546,0.000001028508,0.0003463828],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001847383,"threshold_uncertainty_score":0.006180108,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1133570821367069,"score_gpt":0.4271345216535918,"score_spread":0.3137774395168849,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}